Table 1 Baseline characteristics of study subjects
Characteristic | Total | Ramipril (n = 10) | Telmisartan (n = 10) | P value |
|---|---|---|---|---|
Age, years | 57.9 ± 11.3 | 55.9 ± 11.2 | 59.8 ± 11.7 | 0.449 |
Male, n (%) | 12 (60%) | 8 (80%) | 4 (40%) | 0.17 |
Traditional risk factors | ||||
Diabetes mellitus, n (%) | 5 (25%) | 2 (20%) | 3 (30%) | 1.0 |
Current smoking, n (%) | 5 (25%) | 4 (40%) | 1 (10%) | 0.303 |
Systolic blood pressure, mmHg | 155 ± 8.04 | 151 ± 7.49 | 159 ± 6.83 | 0.028 |
Diastolic blood pressure, mmHg | 87.2 ± 12.0 | 90.6 ± 9.00 | 83.7 ± 14.0 | 0.08 |
Pulse pressure, mmHg | 67.7 ± 14.9 | 60.3 ± 12.4 | 75.0 ± 14.0 | 0.034 |
Mean blood pressure, mmHg | 110 ± 8.25 | 111 ± 6.21 | 109 ± 10.1 | 0.518 |
Major laboratory findings | ||||
Fasting blood glucose, mg/dL | 119 ± 44.2 | 104 ± 9.86 | 128 ± 55.1 | 0.77 |
HbA1c, % | 5.93 ± 0.68 | 5.70 ± 0.62 | 6.6 | 0.18 |
Total cholesterol, mg/dL | 185 ± 40.0 | 186 ± 43.2 | 184 ± 40.1 | 0.954 |
HDL cholesterol, mg/dL | 47.7 ± 9.26 | 47.3 ± 9.37 | 48 ± 10.0 | 0.936 |
LDL cholesterol, mg/dL | 113 ± 32.3 | 104 ± 32.3 | 122 ± 32.7 | 0.423 |
Triglyceride, mg/dL | 180 ± 101 | 163 ± 93.2 | 197 ± 114 | 0.521 |
Potassium, mmol/L | 4.31 ± 0.294 | 4.41 ± 0.219 | 4.16 ± 0.344 | 0.135 |
hs-CRP, mg/dL | 0.433 ± 0.825 | 0.085 ± 0.06 | 1.13 ± 1.27 | 0.364 |
Reactive hyperemia index | 1.87 ± 0.273 | 1.94 ± 0.284 | 1.80 ± 0.258 | 0.272 |